CVA Family Office’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.24K Buy
23
+8
+53% +$2.83K ﹤0.01% 1042
2026
Q1
$4.82K Buy
+15
New +$4.47K ﹤0.01% 1250
2022
Q1
Sell
-10
Closed -$2K 976
2021
Q4
$2K Buy
+10
New +$1.81K ﹤0.01% 843
2021
Q3
Sell
-50
Closed -$9K 684
2021
Q2
$9K Buy
+50
New +$9.04K ﹤0.01% 677

Other funds holding MSGS

CVA Family Office's MSGS Position: Q2 2026 in Review

CVA Family Office increased its Madison Square Garden (MSGS) stake by 53% in Q2 2026, buying an estimated $2.83K and bringing the position to 23 shares worth $9.24K. The position accounts for ﹤0.01% of the portfolio, ranked #1042.

CVA Family Office first reported a position in MSGS in Q2 2021 and has held it in 4 quarters since. 468 funds tracked by Wall St. Rank hold MSGS as of Q2 2026.

  • CVA Family Office held 23 shares of Madison Square Garden worth $9.24K as of Q2 2026.
  • CVA Family Office bought 8 Madison Square Garden shares in Q2 2026, an estimated $2.83K.
  • Madison Square Garden made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1042 holding.
  • CVA Family Office first reported a position in Madison Square Garden in Q2 2021 and has held it in 4 quarters since.
  • 468 funds tracked by Wall St. Rank held Madison Square Garden as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.